Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential


Indivior Share Chat (INDV)



Share Price: 43.75Bid: 43.94Ask: 44.03Change: -1.19 (-2.65%)Faller - Indivior
Spread: 0.09Spread as %: 0.20%Open: 44.07High: 45.40Low: 43.04Yesterday’s Close: 44.94


Share Discussion for Indivior




View all INDV Messages

Please login or register to post a message on Share Chat.

Posts per page:

Meetup
Posts: 41
Opinion:No Opinion
Price:49.02
RE: Market anomaly...
25 May '19
research analyst many thanks for valuable inputs. happy to confirm that i am here for long term investment as well. it is indeed encouraging that yesterday i realized that i am playing in same board with newtyn management. cheers.
 
ResearchAnalyst1
Posts: 143
Opinion:Strong Buy
Price:49.02
Market anomaly...
25 May '19
Meetup, nice try but unfortunately that is old news. More to the point, and had you bothered to browse through the company's RNS', you'll notice that the company's statement on the 'Grand Jury's indictment in the Western District of Virginia' was issued on April 10 2019, same date as that spurious article and all related to the 'alleged federal criminal investigation' initiated by the Department of Justice in December 2013 which is rapidly emerging to be a nonsense.

Meetup, in case you're not aware, fresh data, since the April 10 RNS that saw the company's stock plummet from 105.95p to 30p, has shown that the Sublocade opioid addiction treatment is more effective at higher doses.

Patients who were given 300mg doses remained in treatment longer and had a higher study completion rate than those treated with a 100mg dose.

On average, those on the 300mg dosage also remained abstinent for longer.

The findings were consistent with previous reports that injecting heroin addicts benefitted from higher doses of buprenorphine – the main ingredient in Suboxone. The company is now running additional studies to further characterise the patients for whom a higher maintenance dose of SUBLOCADE may be warranted.

It's also worth remembering that the company recently found that Buprenorphine reduced the extent of respiratory depression in people taking the synthetic opioid Fentanyl. This is a highly positive development.

But, regardless, the company's staggering fundamentals means that the stock is materially oversold. To this end, bargain hunters like the uber-savvy Newtyn Management are exploiting this extraordinary market anomaly. On this point, I would suggest you do the same as the company's share price is unlikely to remain at these shockingly low levels for too long.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.